Cancer pathways' target not validated by clinical results.
Ratner
M
M
D011125:Adenomatous Polyposis Coli / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D001709:Biotechnology / Q000191:economics*; D002986:Clinical Trials as Topic / Q000191:economics; D004345:Drug Industry / Q000191:economics; D006801:Humans; D007449:Investments; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D013467:Sulindac / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use
D000970:Antineoplastic Agents; D010726:Phosphodiesterase Inhibitors; D013467:Sulindac; C025463:sulindac sulfone